Neuroendocrine Carcinoma of the Gallbladder
Servet Güreşçi
Abstract
Open-access reader
Servet Güreşçi
Abstract
Open-access reader
Open Access Letter to Editor was diagnosed.He received adjuvant chemotherapy with 5-flurouracil and cisplatin for 2 months but could not tolerate.He died of metastatic disease and complications after 6 months.Due to lack of systemic symptoms, NECs often present at an advanced stage with only 10% of cases confined to the AbstractNeuroendocrine tumors are the rarest tumors of gallbladder.The most agressive variant is neuroendocrine carcinoma that is seen about 0.5% of all gallbladder carcinomas.We report a case of neuroendocrine carcinoma diagnosed in a 89 year old patient which was diagnosed in a cholesistectomy specimen performed for cholelithiasis.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Open Access Letter to Editor was diagnosed.He received adjuvant chemotherapy with 5-flurouracil and cisplatin for 2 months but could not tolerate.He died of metastatic disease and complications after 6 months.Due to lack of systemic symptoms, NECs often present at an advanced stage with only 10% of cases confined to the AbstractNeuroendocrine tumors are the rarest tumors of gallbladder.The most agressive variant is neuroendocrine carcinoma that is seen about 0.5% of all gallbladder carcinomas.We report a case of neuroendocrine carcinoma diagnosed in a 89 year old patient which was diagnosed in a cholesistectomy specimen performed for cholelithiasis.
Key concepts: Neuroendocrine carcinoma, Gallbladder, Carcinoma, Medicine, Neuroendocrine tumors, Pathology, Internal medicine, General surgery